Explore
Immunotherapy in Myeloma
0 Ungluers have
Faved this Work
Login to Fave
Immunotherapy in multiple myeloma, first investigated with allogeneic stem cell transplantation, is now a major pillar in the treatment of multiple myeloma. CAR-T-cell technology, monoclonal or bispecific antibodies, as well as new forms of cellular therapy, have revolutionized the treatment of this hematological malignancy.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 30 times via unglue.it ebook links.
- 30 - pdf (CC BY) at Unglue.it.
Keywords
- allogeneic stem cell transplantation
- allogeneic transplantation
- Antibodies
- antibody-drug conjugates
- BCMA
- bi-specific T cell engagers
- bispecific
- CAR T
- CAR T-cells
- cell therapy
- chimeric antigen receptor
- cytokine-release syndrome
- daratumumab
- donor lymphocyte infusion
- graft-versus-myeloma
- immunoconjugates
- Immunomodulation
- Immunotherapy
- medicine
- monoclonal
- multiple myeloma
- myeloablative
- Myeloma
- n/a
- new drugs
- NK cells
- non-myeloablative
- prophylaxis
- relapse
- Salvage
- target antigen
Links
DOI: 10.3390/books978-3-0365-2907-3Editions